LWANC
CDAK

Laurel Wealth Advisors (North Carolina)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 710
2022
Q1 		$1K Hold
100
– – ﹤0.01% 655
2021
Q4 		$1K Hold
100
– – ﹤0.01% 655
2021
Q3 		$2K Hold
100
– – ﹤0.01% 620
2021
Q2 		$2K Buy
+100
New +$2K ﹤0.01% 698